Saturday, 20 July 2019

Pharma News

  • MHRA issues import alert to Wockhardt's India plant

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 09 Jul, 2013

    Singapore: About two months after the US Food and Drug Administration (US FDA) issued a Form 483 to Wockhardt for drug quality issues, the company has run into trouble with UK's Medicines a...Read more

  • Cancer claimed 8.2 mn lives in 2012: UN

    Pharma |  Analysis | By BioSpectrum Bureau  | 0 Comment | 04 Feb, 2014

    Singapore: Cancer is the biggest cause of mortality worldwide as the killer disease claimed an estimated 8.2 million lives in 2012 and the number of cases is set to rise by 75 percent in co...Read more

  • Protagonist, Ironwood expand peptide R&D deal

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 21 Dec, 2012

    Singapore: US-based Protagonist Therapeutics and Australia-based Ironwood Pharmaceuticals expanded their research collaboration leveraging Protagonist's proprietary disulfide‐rich pep...Read more

  • US Pharma: Intitate dialogue to resolve IP issues

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 05 Jul, 2014

    Singapore: Corporate executives attending the day-long "US-India BioPharma and Healthcare Summit" organised by the US-India Chamber of Commerce said that they should not be considered adver...Read more

  • UK recommends BMS's Yervoy for skin cancer

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 02 Nov, 2012

    Singapore: National Institute of Health and Clinical Excellence (NICE) has decided to recommend Bristol-Myers Squibb's YERVOY (ipilimumab), which is approved in the European Union for the t...Read more

  • Himalaya enters nutraceutical segment

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 29 Jun, 2012

    The Himalaya Drug Company recently launched HiOwna-Jr, a prescription-based nutritional supplement for kids, that promotes physical and mental growth, marking its entry into the $1480 milli...Read more

  • Lonza produces Bionomics' stem cell cancer drug

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 25 Apr, 2013

    Singapore: Bionomics has initiated manufacturing activities for BNC101, its lead anti-cancer stem cell candidate following completion of key preclinical studies. Lonza will manufacture BNC1...Read more

  • China Botanic gets warning letter from NY exchange

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Singapore: China Botanic Pharmaceutical, China based biopharmaceutical company, has received a warning letter from the NYSE MKT LLC that the Company is not in compliance with Section 803(B)...Read more

  • Asia kills big pharma monopoly dream

    Pharma |  Analysis | By BioSpectrum Bureau  | 0 Comment | 16 Apr, 2013

    Indian apex court has made its intentions clear with the rejection of Novartis' plea to obtain patent protection for cancer drug Glivec in India. The Supreme Court of India will not encoura...Read more

  • Takeda receives Japanese nod for Adcetris

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 21 Jan, 2014

    Singapore: Japanese pharma major Takeda Pharma has announced that it has received approval of Adcetris (brentuximab vedotin) from the Japanese Ministry of Health, Labour and Welfare (MHLW)....Read more

  • TauRx gets $10.5 mn funding from Dundee Corp

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 05 Mar, 2013

    Singapore: Singapore-based TauRx Pharmaceuticals recieved equity investment of $10.5 million from Toronto's Dundee Corporation. The investment will be used by TauRx primarily to support the...Read more

  • Zebrafish holds clue to drug-resistant epilepsy: NIH

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 04 Sep, 2013

    Singapore: According to a research by scientists at the University of California, San Francisco (UCSF), US, zebrafish carrying a specific mutation may help researchers discover treatments f...Read more

  • Irish firm's track-&-trace system to curb fake drugs

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 19 Jun, 2013

    Singapore: Horizon, an Irish engineerng consultancy firm, has completed testing of its new tracking system that aims at eliminating the use of counterfeit drugs. Leading the battle against...Read more

  • FDA approves new labeling for Merck's HIV drug

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 03 Jul, 2013

    Singapore: Merck has received US FDA nod for new labeling for Isentress (raltegravir) film-coated tablets, Merck's integrase inhibitor for the treatment of HIV-1 infection in adult patients...Read more

  • Mylan launches generic version of Sporanox

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 30 Jul, 2012

    Singapore: Mylan Pharmaceuticals received final approval from the US FDA for its abbreviated new drug application (ANDA) for Itraconazole Capsules, 100 mg. This product is the generic versi...Read more

  • F&S: Life Science companies can't afford to miss the next big thing

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Singapore: The top global pharmaceutical companies are employing new growth strategies to counter mounting industry challenges like patent expiration of several blockbuster drugs, as well ...Read more

  • Sosei initiates oropharyngeal candidiasis trial

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 13 Mar, 2013

    Singapore: Sosei Group's Japanese subsidiary initiated a phase III trial for SO-1105 for the treatment of oropharyngeal candidiasis. The study is an open-label, randomised, multiple centr...Read more

  • AstraZeneca boosts drug pipeline with $272 mn deal

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 09 Oct, 2012

    Singapore: AstraZeneca and Ardelyx entered into a worldwide exclusive licensing agreement for the latter's NHE3 inhibitor programme, including the phase II-ready lead compound RDX5791, for ...Read more



Podcast

 

Survey Box

Is Blockchain offering a solution to the healthcare industry?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls